{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:30:23Z","timestamp":1771327823732,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Tianjin Chasesun Pharmaceutical Co., Ltd"},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-144"],"award-info":[{"award-number":["2022-PUMCH-A-144"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-033"],"award-info":[{"award-number":["2022-PUMCH-B-033"]}]},{"name":"Jinqiao Project of Beijing Association of Science and Technology","award":["ZZ19005"],"award-info":[{"award-number":["ZZ19005"]}]},{"name":"Drug Development and Application of Chinese Pharmacological Society","award":["2019DL001"],"award-info":[{"award-number":["2019DL001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s12325-023-02521-1","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T09:04:05Z","timestamp":1685091845000},"page":"3186-3198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety, Tolerability, and Pharmacokinetics of Kukoamine\u00a0B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase\u00a0I Study"],"prefix":"10.1007","volume":"40","clinical-trial-number":[{"clinical-trial-number":"nct02690961","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Qian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenlei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"2521_CR1","unstructured":"Chakraborty RK, Burns B. Systemic inflammatory response syndrome. Treasure Island: StatPearls. 2022."},{"key":"2521_CR2","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1582-4934.2008.00366.x","volume":"12","author":"F Lupu","year":"2008","unstructured":"Lupu F. \u201cCrossroads in sepsis research\u201d review series overview of the pathophysiology of sepsis. J Cell Mol Med. 2008;12:1072\u20133.","journal-title":"J Cell Mol Med"},{"key":"2521_CR3","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/B978-1-4160-2591-7.10106-7","volume-title":"Small animal critical care medicine","author":"EM Boller","year":"2009","unstructured":"Boller EM, Otto CM. Sepsis. In: Silverstein DC, Hopper K, editors. Small animal critical care medicine. Saint Louis: Saunders; 2009. p. 454\u20138."},{"key":"2521_CR4","first-page":"1","volume-title":"Vascular responses to pathogens","author":"FNE Gavins","year":"2016","unstructured":"Gavins FNE. Sepsis. In: Gavins FNE, Stokes KY, editors. Vascular responses to pathogens. Boston: Academic; 2016. p. 1\u20139."},{"key":"2521_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840\u201351.","journal-title":"N Engl J Med"},{"key":"2521_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"},{"key":"2521_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026132","volume":"100","author":"I Nagata","year":"2021","unstructured":"Nagata I, Abe T, Ogura H, Kushimoto S, Fujishima S, Gando S. Intensive care unit model and in-hospital mortality among patients with severe sepsis and septic shock: a secondary analysis of a multicenter prospective observational study. Medicine (Baltimore). 2021;100: e26132.","journal-title":"Medicine (Baltimore)"},{"key":"2521_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5492\/wjccm.v10.i4.66","volume":"10","author":"J Pravda","year":"2021","unstructured":"Pravda J. Sepsis: evidence-based pathogenesis and treatment. World J Crit Care Med. 2021;10:66\u201380.","journal-title":"World J Crit Care Med"},{"issue":"102","key":"2521_CR9","first-page":"18","volume":"2019","author":"J Lee","year":"2013","unstructured":"Lee J, Levy MM. Treatment of patients with severe sepsis and septic shock: current evidence-based practices. R I Med J. 2013;2019(102):18\u201321.","journal-title":"R I Med J"},{"key":"2521_CR10","unstructured":"Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett\u2019s principles and practice of infectious diseases. E-Book: Elsevier Health Sciences; 2019."},{"key":"2521_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fimmu.2013.00109","volume":"4","author":"M Matsuura","year":"2013","unstructured":"Matsuura M. Structural modifications of bacterial lipopolysaccharide that facilitate Gram-negative bacteria evasion of host innate immunity. Front Immunol. 2013;4:109.","journal-title":"Front Immunol"},{"key":"2521_CR12","doi-asserted-by":"crossref","unstructured":"Briassouli E, Tzanoudaki M, Daikos G, et al. 0104. Modulatory effects of heat shock with or without glutamine compared to LPS on peripheral blood mononuclear cells heat-shock-protein 90\u03b1 expression in severe sepsis and trauma. Intensive Care Med Exp. 2014;2(Suppl 1):14.","DOI":"10.1186\/2197-425X-2-S1-P14"},{"key":"2521_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.5483\/BMBRep.2019.52.11.018","volume":"52","author":"TH Kim","year":"2019","unstructured":"Kim TH, Kim D, Lee H, et al. CpG-DNA induces bacteria-reactive IgM enhancing phagocytic activity against Staphylococcus aureus infection. BMB Rep. 2019;52:635\u201340.","journal-title":"BMB Rep"},{"key":"2521_CR14","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.3390\/ijms20143397","volume":"20","author":"TH Kim","year":"2019","unstructured":"Kim TH, Park J, Kim D, et al. Anti-bacterial effect of CpG-DNA involves enhancement of the complement systems. Int J Mol Sci. 2019;20:3397.","journal-title":"Int J Mol Sci"},{"key":"2521_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2172-2-11","volume":"2","author":"DA Hume","year":"2001","unstructured":"Hume DA, Underhill DM, Sweet MJ, Ozinsky AO, Liew FY, Aderem A. Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state. BMC Immunol. 2001;2:11.","journal-title":"BMC Immunol"},{"key":"2521_CR16","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.4049\/jimmunol.0901031","volume":"183","author":"D De Nardo","year":"2009","unstructured":"De Nardo D, De Nardo CM, Nguyen T, Hamilton JA, Scholz GM. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages. J Immunol. 2009;183:8110\u20138.","journal-title":"J Immunol"},{"key":"2521_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.645130","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Hu X, Wang T, et al. Exposure-response modeling to support dosing selection for phase\u00a0IIb development of kukoamine\u00a0B in sepsis patients. Front Pharmacol. 2021;12:645130.","journal-title":"Front Pharmacol"},{"key":"2521_CR18","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2147\/DMSO.S247844","volume":"13","author":"Q Zhao","year":"2020","unstructured":"Zhao Q, Li L, Zhu Y, et al. Kukoamine\u00a0B ameliorate insulin resistance, oxidative stress, inflammation and other metabolic abnormalities in high-fat\/high-fructose-fed rats. Diabetes Metab Syndr Obes. 2020;13:1843\u201353.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2521_CR19","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1476-5381.2010.01114.x","volume":"162","author":"X Liu","year":"2011","unstructured":"Liu X, Zheng X, Wang N, et al. Kukoamine\u00a0B, a novel dual inhibitor of LPS and CpG DNA, is a potential candidate for sepsis treatment. Br J Pharmacol. 2011;162:1274\u201390.","journal-title":"Br J Pharmacol"},{"key":"2521_CR20","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/etm.2015.2188","volume":"9","author":"WT Qin","year":"2015","unstructured":"Qin WT, Wang X, Shen WC, Sun BW. A novel role of kukoamine\u00a0B: inhibition of the inflammatory response in the livers of lipopolysaccharide-induced septic mice via its unique property of combining with lipopolysaccharide. Exp Ther Med. 2015;9:725\u201332.","journal-title":"Exp Ther Med"},{"key":"2521_CR21","first-page":"493","volume":"26","author":"J Zhang","year":"2014","unstructured":"Zhang J, Qin W, Lyu W, Shen W, Wang X, Sun B. [Inhibitory effect of kukoamine\u00a0B on lung inflammatory responses in mice with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014;26:493\u20137.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2521_CR22","first-page":"121","volume":"27","author":"W Lyu","year":"2015","unstructured":"Lyu W, Qin W, Zhang J, Shen W, Wang X, Sun B. [Inhibitory effects of Kukoamine\u00a0B on the inflammatory response of small intestine in lipopolysaccharide-induced septic mice and its potential mechanisms]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27:121\u20136.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2521_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpba.2016.09.032","volume":"132","author":"Z Wang","year":"2017","unstructured":"Wang Z, Zhao Q, Li L, et al. Development and validation of a rapid and sensitive UPLC-MS\/MS method for quantification of kukoamine\u00a0B in human plasma: application to a clinical pharmacokinetic study. J Pharm Biomed Anal. 2017;132:1\u20136.","journal-title":"J Pharm Biomed Anal"},{"key":"2521_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jchromb.2016.07.025","volume":"1031","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Li L, Wang Z, et al. Ultra performance liquid chromatography tandem mass spectrometry assay for determination of kukoamine\u00a0B in human blood and urine. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1031:8\u201314.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02521-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02521-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02521-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T05:17:47Z","timestamp":1686806267000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02521-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02521-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"23 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}